Haofan Biology (301393.SZ) released its semi-annual performance report, with a net profit attributable to the parent company of 75.8848 million yuan, an increase of 15.31%.

Zhtng Cijng APP news, Haofan Biology (301393.SZ) released its 2025 interim report, with the company's operating income reaching 270 million yuan, a year-on-year increase of 20.10%. The net profit attributable to the shareholders of the listed company was 75.8848 million yuan, a year-on-year increase of 15.31%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 62.0004 million yuan, a year-on-year increase of 4.58%. The basic earnings per share were 0.71 yuan.